1.5 billion people around the world live with chronic pain, but traditional pharma drugs are often problematic.
Medicinal Cannabis offers a solution as it contains cannabinoids, supporting the human endocannabinoids system.
Agrinco stems from 10+ years of research and hands-on experience, to manufacture medicinal cannabis in Spain and distribute those to patients around the world.
We strive to deliver reliable and affordable cannabis medicins
Why
MEETING THE EVOLVING NEEDS OF PATIENTS AND DOCTORS
In a world where patients and healthcare professionals seek reliable solutions, Agrinco aims to be a dependable source of quality and consistency. We acknowledge that the landscape of medicinal cannabis is evolving rapidly, with patients and doctors alike recognizing the benefits medicinal cannabis and a broader range of delivery methods.
How
YOUR RELIABLE SUPPLIER
Agrinco is here to ensure access to products distributors, doctors and patients need. We will develop a product range with dedication practical, innovative, and affordable medicinal cannabis solutions. Our plans include producing a range of quality products that address the unique needs of patients and the requirements of healthcare professionals.
Agrinco takes an asset-light approach, drawing from our many years of industry experience. We leverage the latest technology and existing pharmaceutical facilities to reduce our capital expenditure, shorten our time to market, and increase returns for our investors. Our pragmatic approach is designed to deliver results.
OUR BUSINESS MODEL
Who
MEET THE TEAM
More than 15 years of experience in the industry
Harry Wildschut
CEO
Founded Sanoid Isolates in 2018 with a vision to deliver the incredible benefits of the cannabis plant to patients and doctors around the world in a way easy to use, reliable to prescribe, and at affordable costs.
40 years of international sales, marketing and general management experience with leading brands and manufacturers in various industries. Travelled all over the world and landed in Spain to build a leading manufacturing company of medicinal cannabis.
Ignacio Aguirre
Co-Founder & COO
Accomplished entrepreneur and project manager with expertise in large-scale infrastructure projects in Africa. Demonstrates exceptional leadership, strategic thinking, and a commitment to driving positive change in healthcare, agriculture, and other sectors. Known for an innovative mindset in navigating emerging markets and pioneering new solutions.
Pedro Perez
Financial Advisor
CEO of Infinitto Capital, a Spanish mid-cap M&A boutique. He is also Board Member of several companies. Previously he was in the M&A team at J.P Morgan both in London and Madrid offices.
Invest in our vision
We invite investors to help us fund our company and build the foundation for a promising future. We look to fund in 2 fundraising rounds, to remain agile in adapting to market demand.
With our current early-stage fundraising, we plan to deliver proof of concept and positive operational cashflow early 2025.
Our second round of A-series are planned for 2026 to expand our capacity. Our total required funding for the next 2 to 3 years are planned to be between € 1.5 M and € 3.5M.
Partner in our Future
Consumer brands and distributors are invited to collaborate with us as launching customers for our first product launches early 2025. We seek commercial partnerships, forging strong relationships in bringing medicinal cannabis solutions to patients and doctors.
CONTACT US
Count on Agrinco to be your trusted partner in delivering high-quality, patient-centric medicinal cannabis solutions. Welcome to a future marked by steady growth and success.